Turn Therapeutics, Inc. (TTRX)
4.68
+0.74
(+18.78%)
USD |
NASDAQ |
Jan 02, 16:00
4.56
-0.12
(-2.56%)
After-Hours: 20:00
Turn Therapeutics Shareholders Equity (Quarterly): 0.5567M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Nektar Therapeutics | 85.09M |
| Bluejay Diagnostics, Inc. | 3.693M |
| Apogee Therapeutics, Inc. | 586.34M |
| CEL-SCI Corp. | 15.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.350M |
| Total Liabilities (Quarterly) | 3.794M |